⚠️ Uptrend Under Pressure Severe risk · 99 · Institutional selling is building — 6 distribution days in the last 25 sessions. · 6 distribution days (SPY) Full briefing → Jul 28
Simple research view

CAH · Cardinal Health, Inc.

$229.35 latest stored close
Detected setup VCP

Watch · Quality 22/100

2 independent risk warnings also present. Review before relying on the bullish setup.

Ask about CAH

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

Scans / Distribution Services / CAH

$CAH

Cardinal Health, Inc.

Cardinal Health, Inc. is a large-cap Medical Distributors company in the Distribution Services sector with a market cap of $54B.

Buy · 64 Distribution Services Medical Distributors stock Stage 2 · Advancing Base 2 Data 55m ago
$229.35 latest close
Council read · 6 methods

Watch — evidence is building

0 buyable · 5 watch · 1 avoid. Review the observed passes and blockers before reading the chart.

Earnings-risk mode

Normal technical setup

Tuesday, August 18, 2026 Time not confirmed No sourced report session or clock time

Deterministic evidence

CAH+0.58%
Broad market · SPY+0.02%
Same completed session window ending 2026-07-27. +0.56 points vs SPY. Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

AI interpretation (optional)

Ask a Legend to interpret the evidence only after reviewing the deterministic event timing and relative reaction.

Interpret this evidence AI output is commentary, not scanner evidence or a sizing recommendation.
Price $229.35 Jul 27 close
52W High $243.21 -5.7%
52W Low $137.75
Wks Since High 2w
Base Depth -9.4%
Tight Wks 1
Base B2
SMA 50 $219.11
SMA 200 $207.23
Avg Vol 2,358,315
RS Rank 76
RS vs High -7.4%
RS Slope -2.7% ▼
Grp Rank #26/64
ADR% 2.2%
ATR(14) $5.08 (2.2%)
Rel Vol (today) 0.47×
Vol Pace N/A
U/D Vol 0.49
A/D Days 15A / 12D
A/D Rating A
VDU Bars 0/10 d
Power Trend 2d
Earnings 21d
$137.75
$243.21 87%

CAH Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for CAH.

Create Free Account
Setup Quality B 4/7 signals
Jul 24: 75 (Trend Only)Jul 27: 55 (MA Pullback)Jul 28: 55 (VCP)55 Score trend
✓ Stage 2 · Advancing ✗ Power Trend 2d ✗ RS New High ✓ Trend 8/8 ✗ No Pattern ✓ CANSLIM 76.5 (B) ✓ Gatekeeper Base #2 (B)

See the full conviction stack.

Unlock Insights

Technical Analysis Report Card

$CAH · $229.35 · as of 2026-07-27 · multi-factor read
64
/ 100
Buy

Trend · Daily / Weekly / Monthly

Daily ▬ Sideways / consolidating
Weekly ▲ Uptrend
Monthly ▲ Uptrend

Moving Averages

50-day$219.11 ↑
100-day$213.17 ↑
200-day$207.23 ↑
Bullish (50 > 200)

RSI (14)

Reading53.3 · Neutral

Neutral — momentum is balanced between buyers and sellers.

MACD (12/26/9)

StateWeakening
Histogram-1.508

Weakening — MACD slipped below its signal line. Histogram expanding.

Bollinger Bands (20,2)

%B / Width39% · 9.7%

Mid-band — no directional band edge in play.

Volume · Buyer vs Seller

Up/Down vol0.49 · Distribution
Rel volume0.47×

Distribution — volume is concentrated on down days; sellers dominate. Recent volume is easing versus its baseline.

Support & Resistance

R · $230.81swing level
R · $233.60swing level
R · $243.2152-week high
Price · $229.35now
S · $213.58swing level
S · $205.57swing level
S · $199.95swing level

Fibonacci · Uptrend swing

23.6% ◄ price here$228.40
38.2%$219.24
50.0%$211.83
61.8%$204.42
78.6%$193.88

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for CAH — plus the full 495-symbol scanner and Ask-the-Legends chat.
🔒 Start your 7-day free trial →
Weekly uptrendMonthly uptrendAbove 200-day MA50/200 bullishVolume distribution
Want this read in a legend's voice? 💬 Ask a Legend about CAH
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 🟡 5 of 6 legends are Watching — building, not yet a confirmed buy.
Watch
Minervini B

Trend-template read: 9/12 pass; wait for the soft misses to improve.

Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $229.35, MA150 $213.56, MA200 $207.23
1.2 150-day MA > 200-day MAMA150 $213.56 vs MA200 $207.23
Failing evidence
2. Quarterly EPS growth ≥ 25%From SEPA scan
2. ROE ≥ 17%From SEPA scan
9/12 checks
Avoid
O'Neil D

CANSLIM read: fails L: RS rank ≥ 80 (IBD leadership).

Passing evidence
C: Quarterly EPS acceleration ≥ 25%CANSLIM grade B
N: Near 52-week high or RS line new high5.7% below high | RS line new high: False
Failing evidence
L: RS rank ≥ 80 (IBD leadership)RS rank 73
A: Annual earnings & revenue qualityRev -1.9%
3/8 checks
Watch
Weinstein B

Stage-analysis read: Stage 2 is present; 1 supporting checks need improvement.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $229.35 vs MA200 $207.23
Failing evidence
Volume expansion above averageVolume ratio 0.47x
6/7 checks
Watch
Livermore B

Pivotal-point read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$229.35
Relative strengthRS 73
Failing evidence
Volume vs average0.47x
Pivotal point cleared on expanding volumeNot confirmed
4/6 checks
Watch
Darvas B

Box-theory read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$229.35
Relative strengthRS 73
Failing evidence
Volume vs average0.47x
Box top broken on heavy volumeNot confirmed
4/6 checks
Watch
Wyckoff B

Supply-and-demand read: constructive evidence is present, but volume vs average is unresolved.

Passing evidence
Price$229.35
Relative strengthRS 73
Failing evidence
Volume vs average0.47x
Sign of Strength confirmed on expanding volumePrice hasn't cleared the pivot yet — confirmation pending
4/6 checks
Breakout Health

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▼ Falling
126RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +7 A
A: 17 D: 10 Net: +765 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini SEPA criteria · 2/7 met
C 2/7 SEPA
Separate score from the 8-point Trend Template (8/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ
Revenue growth ≥20% YoY -2%
Gross margin ≥30%
ROE ≥17%
RS rating ≥80 (leadership) 73
Stage 2 uptrend (Weinstein) Stage 2
Within 25% of 52W high -5.7%

Method Playbook

📋 Trade it like O'Neil EXACT LEVELS · PRO
Minervini O'Neil Livermore Weinstein Darvas Wyckoff
O'Neil D · Avoid — The deterministic methodology check is Avoid; wait until the blocking criteria are resolved.
Pivot
Pro level
Published-method rule: Use the proper base pivot or handle high after CANSLIM leadership and market-direction checks are satisfied.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require a breakout through the pivot on volume at least 40% above average; the valid buy zone ends 5% above the pivot.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Use the setup's structural stop with a hard 7–8% maximum-loss ceiling from the actual entry.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Protect progress under constructive support such as the 21-day or 10-week line; a stop may ratchet higher but never lower.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit on the hard loss limit, a decisive support break, or a rule-based climax/distribution signal; a normal 20–25% advance is reviewed rather than assumed permanent.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →
The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →

Forming Patterns (predictive — not confirmed)

Head & Shoulders bearish near confirmation
90% built

Possible head & shoulders top — not confirmed. Watch for a daily close below ~222.92 (neckline) to confirm, with measured-move risk toward ~202.63. A push back above 230.61 weakens the pattern; reclaiming 243.21 invalidates it.

Confirms below 222.92
Invalidates at 243.21
Left Shoulder 233.60
Head 243.21
Right Shoulder 230.61
Neckline 222.92
Target 202.63

LS 233.60 / head 243.21 / RS 230.61, neckline ~222.92, vol_fading=yes

Predictive pattern recognition is educational — most forming structures never confirm. Wait for the confirmation level before treating this as a setup.

Pattern Analysis

VCP ⚠ 3rd-stage base ⚠ Rising wedge (broke lower) ⚠ Head & shoulders top forming
55.0 score
RS Score 73
Trend 8/8
CANSLIM 76.5* (B)
C1 8.3%
C2 5.5%
2 contractions 9.4% depth ✓ tightening ✓ vol dry ✓ near pivot ✓ right side Q: 81
Why This Setup? D+W Confluence
VCP

2T: 8% → 6% (tightening, higher lows), depth=9.4%, vdu=0.73, state=actionable, quality=81 | Strong trend (8/8) | Good RS (73) | High-confidence pattern (100%) | Volume drying up (bullish) | Stage 2 | Readiness 79/100 (approaching) | CANSLIM 76.5 (B) | ⚠ 3rd-stage base; Rising wedge (broke lower); Head & shoulders top forming

The Universal Edge Check

The panel is uneasy

Too many universals unmet — this leans closer to a guess than a trade.

1/7 universals met
Why these seven? → The Universal Edge

Minervini Trend Template

8/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $229.35 vs SMA150 $213.56 / SMA200 $207.23
SMA 150 above SMA 200 SMA150 $213.56 vs SMA200 $207.23
SMA 200 trending up Slope +7.91 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $219.11
Price above SMA 50 $229.35 vs SMA50 $219.11
30%+ above 52W low +66.5% from $137.75
Within 25% of 52W high -5.7% from $243.21
RS score above 70 RS 73

Fundamentals

52W Range
87%
Mkt Cap SEC
54.0B
Rev YoY
-2%
EPS TTM
$6.45
P/E TTM
35.6x
Float
235M
Insider
No Buy

Company

Legend AI snapshot
Cardinal Health, Inc.
CAH · NYSE · Distribution Services · Medical Distributors
$229.35latest close $54.0Bmarket cap 76RS rank 55setup score
O'Neil · Grade Card
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
B 76.5* CANSLIM * disqualified on M
C · Curr. EPS
100
A · Annual EPS
53
N · New Highs
100
S · Supply/Demand
70
L · Leader RS
73
I · Inst. Spons.
100
M · Market
30

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
8/8
W. RS
78
W. Support
$180.45
W. Resist
$243.21
W. Patterns
Cup & Handle
Weekly Structure

Scan History

20× streak
Jul 24: 75 (Trend Only)Jul 27: 55 (MA Pullback)Jul 28: 55 (VCP)55
Jul 28
VCP ✓ Gate
55
Jul 27
MA Pullback ✓ Gate
55 0.0%
Jul 24
Trend Only ✓ Gate
75 +0.6%

Get the full picture on CAH

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 495+ symbols daily.

Start 7-Day Free Trial